Retrospective Study of Airway Management in Dutch ED's

July 1, 2024 updated by: Peter Veldhuis, Medical Centre Leeuwarden

A Retrospective Study on the Practice and Safety of Airway Management in Dutch Emergency Departments

Describing characteristics of the practice of airway management in Dutch emergency departments, including information about patient demographics, indications, performer characteristics, equipment and medication used and complications due to intubation.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Endotracheal intubation can be a lifesaving intervention for critically ill patients in the emergency department (ED). Endotracheal intubation is, however, a high-risk procedure with many potential complications, which seem to be even more prevalent when carried out in the ED compared to for example the operating theater. This is possibly due to multiple reasons such as a sicker population, non-elective setting, a higher variability among indications for intubation or competence of providers.

Internationally, large registries were established and multiple observational studies have been performed to gain more information about the methods, safety and complications of intubations in the ED. While in recent years these studies have added to our knowledge of ED airway management, there is still a lack of high-quality studies and there is a strong argument for increased research. To date, no studies have been published of airway management in Dutch EDs. The investigators therefore have no knowledge about any factors possibly influencing intubation outcomes and complications nor comparability with international data. Among these are factors that have been associated with preventable harm and death and insight into these factors could be used for improvement of the safety of airway management in Dutch EDs.

This study is therefore intended to provide a comprehensive review of the clinical practice and characteristics of endotracheal intubations within Dutch EDs. The results could potentially be used for comparative analysis against global datasets. Additionally, the insights gained from this study will shed light on existing gaps prevalent in the current registration processes of intubations in the Netherlands. Furthermore, these insights could act as a stepping stone for future investigations that can lead to a deeper understanding of the methodologies, safety protocols, and associated complications of endotracheal intubations within Dutch EDs

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Leeuwarden, Netherlands, 8934AD
        • Recruiting
        • Leeuwarden Medical Centre
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

All patients who underwent endotracheal intubation between 01-01-2019 and 31-12-2023 in the participating ED's (Leeuwarden Medical Centre, VieCuri Medical Centre, Catharina Hospital, Rijnstate Hospital, Zuyderland Medical Centre)

Description

Inclusion Criteria:

  • All patients who underwent endotracheal intubation between 01-01-2019 and 31-12-2023 in the participating ED's

Exclusion Criteria:

  • Patients for which no information about the intubation can be found in the electronic patient chart will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients who underwent the intervention of endotracheal intubation

Inclusion criteria:

All patients who underwent endotracheal intubation between 01-01-2019 and 31-12-2023 in the participating ED's.

Exclusion criteria:

Patients for which no information about the intubation can be found in the electronic patient chart will be excluded from the study.

All endotracheal intubations carried out in the emergency department of one of the participating hospitals in the time period 01-01-2019 - 31-12-2023

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Different complications of endotracheal intubation
Time Frame: At the time of intervention and consequent 1 hour
  • significant decrease of SpO2. Defined as: desaturation of >10% from baseline or as defined by the treating physician
  • significant decrease of blood pressure. Defined as: systolic pressure <90mmHg with a drop of >20% from baseline or as defined by the treating physician.
  • significant increase of blood pressure. Defined as: systolic pressure > 160mmHg with a rise of >20% from baseline, or as defined by the treating physician.
  • significant bradycardia. Defined as: heart rate < 40/min and a drop of > 20% from baseline, or as defined by the treating physician.
  • significant tachycardia. Defined as: heart rate > 160/min and a rise of > 20% from baseline, or as defined by the treating physician.
  • dental or airway trauma
  • oesophageal or mainstem bronchial intubation
  • vomiting or aspiration
  • laryngospasm
  • equipment failure
  • medication error
  • cardiac arrest
  • failed attempt / need for an emergency surgical airway
  • other
At the time of intervention and consequent 1 hour

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intubator characteristics
Time Frame: At the time of intervention and consequent 1 hour
Specialty and function/seniority of the intubator
At the time of intervention and consequent 1 hour
Indication for intubation
Time Frame: At the time of intervention and consequent 1 hour

Indications could be:

Trauma Burns Drowning Overdose/ingestion Respiratory failure Cardiac arrest (active cardiac arrest) Post-cardiac arrest Stroke Seizure Altered mental status due to other cause (if altered mental status due to stroke, intoxication, seizure or post-cardiac arrest then score as the primary cause) Sepsis Cardiac failure Airway obstruction GI bleed Anaphylaxis Other

At the time of intervention and consequent 1 hour
Sedation agent used
Time Frame: At the time of intervention and consequent 1 hour
Ketamine, etomidate, propofol, midazolam
At the time of intervention and consequent 1 hour
Paralytic agent used
Time Frame: At the time of intervention and consequent 1 hour
Rocuronium / Succinylcholine
At the time of intervention and consequent 1 hour
Sedative agent after intubation
Time Frame: At the time of intervention and consequent 1 hour
Propofol Fentanyl Midazolam Morphine Ketamine Other Not indicated
At the time of intervention and consequent 1 hour
Method of intubation
Time Frame: At the time of intervention and consequent 1 hour
Direct laryngoscopy Video (hyperangulated or direct) Fiberoptic Surgical airway
At the time of intervention and consequent 1 hour
Patient characteristics
Time Frame: At the time of intervention and consequent 1 hour
Demographics of the patient who underwent endotracheal intubation. Such as age (years), gender (male/female), weight/obesity (BMI)
At the time of intervention and consequent 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

December 31, 2023

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

March 20, 2024

First Submitted That Met QC Criteria

April 15, 2024

First Posted (Actual)

April 18, 2024

Study Record Updates

Last Update Posted (Actual)

July 3, 2024

Last Update Submitted That Met QC Criteria

July 1, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • EDSAM2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endotracheal Intubation

Clinical Trials on Endotracheal intubation

Subscribe